Catheter Robot Atlas

Commercial and clinical-stage systems · etcath200_wemed2021

ETcath200

ETcath / ETcath200
Beijing WeMed Medical (Weimai) · 2021–2026
ETcath200: main picture1 / 4
Not cleared for distribution. https://www.we-med.com/uploadfile/202509/2d2d043639daec2.png (WeMed product page 冠脉介入手术控制系统 ETcath200, https://www.we-med.com/index.php?c=show&id=661; the same file is the listing image https://www.we-med.com/uploadfile/202509/5289d21516dd81b.png). Licence: press image (company product image). Picture grade A.
Family
Commercial and clinical-stage systems (commercial)
Devices
guidewire, RX balloon/stent catheter (guidewire arm); guiding catheter advance (catheter arm)
Degrees of freedom
N.R. as a count
Push
Friction rollers
Twist
Not reported
Tested up to
Human
Sim-to-real
None found — No simulation-trained controller found for this robot.

Testing

Highest level
Human
What was tested
RCT 73 robot vs 79 manual (yu2025_robot); 20 complex lesions (yang2026_feasibility)
Key numbers
RCT: clinical success 100% both, robot technical success 100%, longer procedure, lower operator dose (yu2025_robot abstract). Complex lesions: 16/20 (80%) technical success, 4 conversions, 61.0+-23.3 min (yang2026_feasibility).

Mechanism

Push (translation)
friction-roller (roller interface per yang2026_feasibility)
Twist (rotation)
N.R.
Device range
N.R.
Target anatomy
coronary (elective PCI low-intermediate risk lesions)

Sensing and interface

Force sensing
guidewire force sensing; claimed resolution 0.01 N (people.cn press)
Leader and haptics
no (visual resistance display; joystick/roller control box)
Imaging
two passive arms on table rails, clear of X-ray equipment
Sterility
single-use sterile cassette kit

Size

Footprint (mm)
N.R.
Mass (kg)
N.R.

Simulation

Simulation model
none found
Sim-trained controller
none found

Versions

Lineage
ETcath200

Sources

  1. Robot-assisted percutaneous coronary intervention: a prospective, multicenter, randomized controlled, non-inferiority clinical trial · Journal of Geriatric Cardiology, 2025 · doi:10.26599/1671-5411.2025.08.008 [yu2025_robot]
  2. Feasibility and Safety of the ETcath200 Robotic PCI System for Complex Coronary Lesions: A Prospective Single-Center Study · Catheterization and Cardiovascular Interventions, 2026 · doi:10.1002/ccd.70488 [yang2026_feasibility]

Notes

Notes
NMPA approval reported March 2025 (people.cn 2025-03-25 citing a Beijing E-Town WeChat post; registration number/date not seen). First robotic PCI at Anzhen Oct 2021 (search). WeMed contributed to NMPA standard YY/T 1994-2025 (web). Possible WeMed neuro product (Weimai) status: under review per yicai 2024.

This record

Read level
full — full text on disk (yang2026) + web
Picture
https://www.we-med.com/uploadfile/202509/2d2d043639daec2.png (WeMed product page 冠脉介入手术控制系统 ETcath200, https://www.we-med.com/index.php?c=show&id=661; the same file is the listing image https://www.we-med.com/uploadfile/202509/5289d21516dd81b.png) ↗ — licence: press image (company product image); grade A
Picture changes
RGBA product render flattened on white; cropped to the drawing with about 4 % margin (0,0)-(1422,1129) of 1422x1182; no erasing; not upscaled
Found by
commercial: Search of commercial and clinical-stage systems.
Data
JSON · YAML: records/robots/etcath200_wemed2021.yaml
Correction
Suggest a correction [repository not created yet]